Manufacturing

Adam Andersen, executive vice president, Pharma, at Informa—the event organizer behind CPHI Frankfurt.

Articles

Pharma supply chains are no longer hidden beyond the reach of ESG agendas, making it important for companies to accelerate adoption of new manufacturing processes and environmental technology

At the Heart of Pharma: ESG has Arrived as a Central Strategy 

Cleo Bern Hartley is a pharma consultant, former pharma analyst, and research scientist.

Biopharma focuses on streamlining biomanufacturing and supply chain issues to drive uptake of cell and gene therapies.

Growth in Cell and  Gene Therapy Market

Alasdair Leckie is operations director at Rephine Ltd, a firm of deeply experienced GMP auditors which proactively help pharmaceutical companies around the world with their supply-chain quality assurance. Alasdair has been with Rephine for nine years and has a Bachelor’s Degree in Chinese and Economics from SOAS University of London.

A new survey has demonstrated that remote audits, brought to the fore thanks to COVID-19, are not necessarily a preferred option for clients. 

Will Remote Pharma GMP Auditing Endure Post-Pandemic?

Suzanne Shelley is contibuting editor to 

Expanded use of data analytics can help to avoid disruptions, but the possibilities cannot be realized without sufficient investment and direct human involvement.

Reducing Blind Spots in the Pharma Supply Chain

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

More than anything else MonkeyPox and COVID-19 have shown that we are interdependent, no matter what continent you call home.

Vaccine Disconnect

Podcasts

In this episode, Grant Playter, assistant editor, sits down with Rosalind Beasley, vice president, Digital Innovation, Dot Compliance, to discuss the current state of the compliance and validation industry.

Drug Solutions Podcast: The Current State of Compliance and Validation

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

In this episode, experts share their insights into important drug packaging advances of the past, present, and future.  

Drug Solutions Podcast: Drug Packaging Advances

Technological advances are progressing pharmaceutical packaging to overcome the challenges of the future.

Getting Proactive with Pharma Packaging

Tanya Landon is a partner, Global Arbitration, Trade and Advocacy at Sidley Austin—an international law firm.

Dorothee Schramm is a partner, Global Arbitration, Trade and Advocacy at Sidley Austin—an international law firm.

As a result of the disruptions caused by the COVID-19 pandemic, global arbitration has adapted to a ‘new normal’.

Trends in International Arbitration: The Fallout from COVID-19

The agency is asking drug manufacturers to ensure a strong supply chain by developing risk management plans.